Cobalt derivatives as promising therapeutic agents

Current Opinion in Chemical Biology

Volumn 17, Issue 2, 2013, Pages 189-196

  Heffern, Marie C ^a   Yamamoto, Natsuho ^a   Holbrook, Robert J ^a   Eckermann, Amanda L ^a   Meade, Thomas J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CISPLATIN; COBALT; DRUG CARRIER;

DRUG ACTIVITY; DRUG EFFICACY; HUMAN; PROTEIN MODIFICATION; REVIEW;

COBALT; COORDINATION COMPLEXES; DRUG DISCOVERY; HUMANS; MODELS, MOLECULAR;

EID: 84876743813     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2012.11.019     Document Type: Review

References (60)

1. Bruijnincx P.C., Sadler P.J. New trends for metal complexes with anticancer activity. Curr Opin Chem Biol 2008, 12:197-206.
2. Hambley T.W. Developing new metal-based therapeutics: challenges and opportunities. Dalton Trans 2007, 4929-4937.
3. Haas K.L., Franz K.J. Application of metal coordination chemistry to explore and manipulate cell biology. Chem Rev 2009, 109:4921-4960.
4. Meggers E. Targeting proteins with metal complexes. Chem Commun 2009, 1001-1010.
5. Schwartz J.A., Lium E.K., Silverstein S.J. Herpes simplex virus type 1 entry is inhibited by the cobalt chelate complex CTC-96. J Virol 2001, 75:4117-4128.
6. Chang E.L., Simmers C., Knight D.A. Cobalt complexes as antiviral and antibacterial agents. Pharmaceuticals 2010, 3:1711-1728.
7. Hall M.D., Failes T.W., Yamamoto N., Hambley T.W. Bioreductive activation and drug chaperoning in cobalt pharmaceuticals. Dalton Trans 2007, 3983-3990.
8. Louie A.Y., Meade T.J. A cobalt complex that selectively disrupts the structure and function of zinc fingers. Proc Natl Acad Sci U S A 1998, 95:6663-6668.
9. Takeuchi T., Bottcher A., Quezada C.M., Meade T.J., Gray H.B. Inhibition of thermolysin and human alpha-thrombin by cobalt(III) Schiff base complexes. Bioorg Med Chem 1999, 7:815-819.
10. Harney A.S., Lee J., Manus L.M., Wang P.J., Ballweg D.M., LaBonne C., Meade T.J. Targeted inhibition of Snail family zinc finger transcription factors by oligonucleotide-Co(III) Schiff base conjugate. Proc Natl Acad Sci U S A 2009, 106:13667-13672.
11. Harney A.S., Meade T.J., LaBonne C. Targeted inactivation of Snail family EMT regulatory factors by a Co(III)-Ebox conjugate. PLoS ONE 2012, 7:e32318.
12. Hurtado R.R., Harney A.S., Heffern M.C., Holbrook R.J., Holmgren R.A., Meade T.J. Specific inhibition of the transcription factor Ci by a cobalt(III) Schiff base-DNA conjugate. Mol Pharm 2012, 9:325-333.
13. Leung C.-H., Chan D.S., Ma V.P., Ma D.-L. DNA-binding small molecules as inhibitors of transcription factors. Med Res Rev 2012, 10.1002/med.21266.
14. Berg T. Inhibition of transcription factors with small organic molecules. Curr Opin Chem Biol 2008, 12:464-471.
15. Harney A.S., Sole L.B., Meade T.J. Kinetics and thermodynamics of irreversible inhibition of matrix metalloproteinase 2 by a Co(III) Schiff base complex. J Biol Inorg Chem 2012, 17:853-860.
16. Takeuchi T., Bottcher A., Quezada C.M., Simon M.I., Meade T.J., Gray H.B. Selective inhibition of human alpha-thrombin by cobalt(III) Schiff base complexes. J Am Chem Soc 1998, 120:8555-8556.
17. Dimiza F., Papadopoulos A.N., Tangoulis V., Psycharis V., Raptopoulou C.P., Kessissoglou D.P., Psomas G. Biological evaluation of non-steroidal anti-inflammatory drugs-cobalt(II) complexes. Dalton Trans 2010, 39:4517-4528.
18. Dimiza F., Papadopoulos A.N., Tangoulis V., Psycharis V., Raptopoulou C.P., Kessissoglou D.P., Psomas G. Biological evaluation of cobalt(II) complexes with non-steroidal anti-inflammatory drug naproxen. J Inorg Biochem 2012, 107:54-64.
19. Tsiliou S., Kefala L.-A., Perdih F., Turel I., Kessissoglou D.P., Psomas G. Cobalt(II) complexes with non-steroidal anti-inflammatory drug tolfenamic acid: structure and biological evaluation. Eur J Med Chem 2012, 48:132-142.
20. Adewuyi S., Kareem K.T., Atayese A.O., Amolegbe S.A., Akinremi C.A. Chitosan-cobalt(II) and nickel(II) chelates as antibacterial agents. Int J Biol Macromol 2011, 48:301-303.
21. Patel M., Chhasatia M., Bhatt B. In vitro bacteriostatic and DNA interaction studies of drug-based mixed-ligand complexes of cobalt(II). Med Chem Res 2011, 20:220-230.
22. Adediji J.F., Olayinka E.T., Adebayo M.A., Babatunde O. Antimalarial mixed ligand metal complexes: synthesis, physicochemical, biological and activities. Int J Phys Sci 2009, 4:529-534.
23. Ajibade P.A., Kolawole G.A. Cobalt(III) complexes of some antimalarial drugs: synthesis, characterization, and in vitro antiprotozoal studies. Synth React Inorg Met 2010, 40:273-278.
24. Sathyadevi P., Krishnamoorthy P., Alagesan M., Thanigaimani K., Thomas Muthiah P., Dharmaraj N. Synthesis, crystal structure, electrochemistry and studies on protein binding, antioxidant and biocidal activities of Ni(II) and Co(II) hydrazone complexes. Polyhedron 2012, 31:294-306.
25. Shreaz S., Sheikh R.A., Bhatia R., Neelofar K., Imran S., Hashmi A.A., Manzoor N., Basir S.F., Khan L.A. Antifungal activity of α-methyl trans cinnamaldehyde, its ligand and metal complexes: promising growth and ergosterol inhibitors. Biometals 2011, 24:923-933.
26. Khatiwora E., Mundhe K., Deshpande N.R., Kashalkar R.V. Anthelmintic activity of transition metal complexes of some benzamides. Der Pharma Chem 2012, 4:1264-1269.
27. Ott I., Schmidt K., Kircher B., Schumacher P., Wiglenda T., Gust R. Antitumor-active cobalt-alkyne complexes derived from acetylsalicylic acid: studies on the mode of drug action. J Med Chem 2005, 48:622-629.
28. Randaccio L., Geremia S., Demitri N., Wuerges J. Vitamin B12: unique metalorganic compounds and the most complex vitamins. Molecules 2010, 15:3228-3259.
29. Petrus A., Fairchild T.J., Doyle R.P. Traveling the Vitamin B12 pathway: oral delivery of protein and peptide drugs. Angew Chem Int Ed Engl 2009, 48:1022-1028.
30. Zobi F., Blacque O., Jacobs R.A., Schaub M.C., Bogdanova A.Y. 17 e- rhenium dicarbonyl CO-releasing molecules on a cobalamin scaffold for biological application. Dalton Trans 2012, 41:370-378.
31. Ruiz-Sanchez P., Koenig C., Ferrari S., Alberto R. Vitamin B12 as a carrier for targeted platinum delivery: in vitro cytotoxicity and mechanistic studies. J Biol Inorg Chem 2011, 16:33-44.
32. Ott I., Kircher B., Bagowski C.P., Vlecken D.H., Ott E.B., Will J., Bensdorf K., Sheldrick W.S., Gust R. Modulation of the biological properties of aspirin by formation of a bioorganometallic derivative. Angew Chem Int Ed Engl 2009, 48:1160-1163.
33. Ott I., Koch T., Shorafa H., Bai Z., Poeckel D., Steinhilber D., Gust R. Synthesis, cytotoxicity, cellular uptake and influence on eicosanoid metabolism of cobalt-alkyne modified fructoses in comparison to auranofin and the cytotoxic COX inhibitor Co-ASS. Org Biomol Chem 2005, 3:2282-2286.
34. Rubner G., Bensdorf K., Wellner A., Kircher B., Bergemann S., Ott I., Gust R. Synthesis and biological activities of transition metal complexes based on acetylsalicylic acid as neo-anticancer agents. J Med Chem 2010, 53:6889-6898.
35. Graf N., Lippard S.J. Redox activation of metal-based prodrugs as a strategy for drug delivery. Adv Drug Deliv Rev 2012, 64:993-1004.
36. Jungwirth U., Kowol C.R., Keppler B.K., Hartinger C.G., Berger W., Heffeter P. Anticancer activity of metal complexes: involvement of redox processes. Antioxid Redox Signal 2011, 15:1085-1127.
37. Schafer F.Q., Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001, 30:1191-1212.
38. Milbank J.B.J., Stevenson R.J., Ware D.C., Chang J.Y.C., Tercel M., Ahn G.O., Wilson W.R., Denny W.A. Synthesis and evaluation of stable bidentate transition metal complexes of 1-(chloromethyl)-5-hydroxy-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinoline (seco-6-azaCBI-TMI) as hypoxia selective cytotoxins. J Med Chem 2009, 52:6822-6834.
39. Wilson W.R., Hay M.P. Targeting hypoxia in cancer therapy. Nat Rev Cancer 2011, 11:393-410.
40. Tomco D., Schmitt S., Ksebati B., Heeg M.J., Dou Q.P., Verani C.N. Effects of tethered ligands and of metal oxidation state on the interactions of cobalt complexes with the 26S proteasome. J Inorg Biochem 2011, 105:1759-1766.
41. Tomco D., Xavier F.R., Allard M.M., Verani Cu.N. Probing chemical reduction in a cobalt(III) complex as a viable route for the inhibition of the 20S proteasome. Inorg Chim Acta 2012, 393:269-275.
42. Ware D.C., Brothers P.J., Clark G.R., Denny W.A., Palmer B.D., Wilson W.R. Synthesis, structures and hypoxia-selective cytotoxicity of cobalt(III) complexes containing tridentate amine and nitrogen mustard ligands. J Chem Soc Dalton Trans 2000, 925-932.
43. Ware D.C., Denny W.A., Clark G.R. [N,N-Bis(2-chloroethyl)-1,2-ethanediamine-N,N']bis(3-methyl-2,4-pentanedionato-O,O')cobalt(III) perchlorate: a potential hypoxia selective anticancer agent. Acta Crystallogr C 1997, C53:1058-1059.
44. Ware D.C., Palmer H.R., Brothers P.J., Rickard C.E.F., Wilson W.R., Denny W.A. Bis-tropolonato derivatives of cobalt(III) complexes of bidentate aliphatic nitrogen mustards as potential hypoxia-selective cytotoxins. J Inorg Biochem 1997, 68:215-224.
45. Ware D.C., Wilson W.R., Denny W.A., Richard C.E.F. Design and synthesis of cobalt(III) nitrogen mustard complexes as hypoxia selective cytotoxins. The X-ray crystal structure of bis(3-chloropentane-2,4-dionato)(RS-N,N'-bis(2-chloroethyl)ethylenediamine)cobalt(III) perchlorate, [Co(Clacac)2(bce)]ClO4. J Chem Soc Chem Commun 1991, 1171-1173.
46. Ahn G.O., Botting K.J., Patterson A.V., Ware D.C., Tercel M., Wilson W.R. Radiolytic and cellular reduction of a novel hypoxia-activated cobalt(III) prodrug of a chloromethylbenzindoline DNA minor groove alkylator. Biochem Pharmacol 2006, 71:1683-1694.
47. Ahn G.O., Ware D.C., Denny W.A., Wilson W.R. Optimization of the auxiliary ligand shell of cobalt(III)(8-hydroxyquinoline) complexes as model hypoxia-selective radiation-activated prodrugs. Radiat Res 2004, 162:315-325.
48. Failes T.W., Cullinane C., Diakos C.I., Yamamoto N., Lyons G.J., Hambley T.W. Studies of a Co(III) complex of the MMP inhibitor marimastat: a potential hypoxia activated prodrug. Chem: Eur J 2007, 13:2974-2982.
49. Wilson W.R., Moselen J.W., Cliffe S., Denny W.A., Ware D.C. Exploiting tumor hypoxia through bioreductive release of diffusible cytotoxins: the cobalt(III)-nitrogen mustard complex SN 24771. Int J Radiat Oncol 1994, 29:323-327.
50. Yamamoto N., Danos S., Bonnitcha P.D., Failes T.W., New E.J., Hambley T.W. Cellular uptake and distribution of cobalt complexes of fluorescent ligands. J Biol Inorg Chem 2008, 13:861-871.
51. Kim B.J., Hambley T.W., Bryce N.S. Visualising the hypoxia selectivity of cobalt(III) prodrugs. Chem Sci 2011, 2:2135-2142.
52. Kozisek M., Cigler P., Lepsik M., Fanfrlik J., Rezacova P., Brynda J., Pokorna J., Plesek J., Gruner B., Grantz Saskova K., et al. Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance. J Med Chem 2008, 51:4839-4843.
53. Rezácová P., Pokorná J., Brynda J., Kozísek M., Cígler P., Lepsík M., Fanfrlík J., Rezác J., Šasková K.G., Sieglová I., et al. Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranes. J Med Chem 2009, 52:7132-7141.
54. Seo W.S., Lee J.H., Sun X., Suzuki Y., Mann D., Liu Z., Terashima M., Yang P.C., McConnell M.V., Nishimura D.G., et al. FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents. Nat Mater 2006, 5:971-976.
55. Fortin J.-P., Wilhelm C., Servais J., Menager C., Bacri J.-C., Gazeau F. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J Am Chem Soc 2007, 129:2628-2635.
56. Saha S., Majumdar R., Dighe R.R., Chakravarty A.R. Enhanced photodynamic effect of cobalt(III) dipyridophenazine complex on thyrotropin receptor expressing HEK293 cells. Metallomics 2010, 2:754-765.
57. Sun Y., Hou Y.J., Zhou Q.X., Chen J.R., Zhang B.W., Wang X.S. A new Co(III)-hypocrellin B complex with enhanced photonuclease activity. J Inorg Biochem 2011, 105:978-984.
58. Roy S., Saha S., Majumdar R., Dighe R.R., Jemmis E.D., Chakravarty A.R. Cobalt(II) complexes of terpyridine bases as photochemotherapeutic agents showing cellular uptake and photocytotoxicity in visible light. Dalton Trans 2011, 40:1233-1242.
59. Kawade V.A., Kumbhar A.A., Kumbhar A.S., Nather C., Erxleben A., Sonawane U.B., Joshi R.R. Mixed ligand cobalt(II) picolinate complexes: synthesis, characterization, DNA binding and photocleavage. Dalton Trans 2011, 40:639-650.
60. Nagababu P., Shilpa M., Latha J.N., Bhatnagar I., Srinivas P.N., Kumar Y.P., Reddy K.L., Satyanarayana S. Synthesis, characterization, DNA binding properties, fluorescence studies and toxic activity of cobalt(III) and ruthenium(II) polypyridyl complexes. J Fluoresc 2011, 21:563-572.